FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1787542384> ?p ?o ?g. }

• W1787542384 endingPage "24" @default.
• W1787542384 startingPage "13" @default.
• W1787542384 abstract "Background:  Oral cyclophosphamide, methotrexate and 5-fluorouracil (CMF) was one of the first combination chemotherapy regimens used as adjuvant chemotherapy for early breast cancer. The value of CMF in reducing both recurrence and mortality from early breast cancer has been firmly established by the overviews of randomized trials of polychemotherapy, which have used CMF as their standard. The purpose of this review is to review the usage of oral CMF and the variants of CMF and to compare both the activity and side-effects of CMF with more modern adjuvant chemotherapy regimens.Results:  There are many variants of CMF but oral (or classical) CMF is probably more effective than intravenous (i.v.) CMF, at least in metastatic disease. When oral CMF is used in early breast cancer it reduces the annual hazard of recurrence by 24% and the annual hazard of mortality by 14% overall, although it appears more effective in younger patients. Anthracycline-based regimens are more effective for reduction of recurrence and mortality than CMF but are associated with more severe acute toxicities and potentially greater risks of long-term toxicities. Taxane-based regimens have not been compared with CMF directly; however, in comparison with anthracycline-based regimens, the early information suggests that taxane-based regimens may be even more effective. The acute toxicities of taxane-based regimens are probably less severe than anthracycline-based regimens, but their long-term toxicities are less well defined.Conclusion:  Oral CMF as adjuvant chemotherapy for early breast cancer is the standard by which newer regimens are compared. Although newer regimens appear more effective than CMF, they may be associated with greater acute and potentially greater long-term toxicities than CMF. Thus, CMF remains the standard by which future regimens should be judged, either directly or indirectly." @default.
• W1787542384 created "2016-06-24" @default.
• W1787542384 creator A5021904433 @default.
• W1787542384 creator A5045781394 @default.
• W1787542384 creator A5047266225 @default.
• W1787542384 date "2005-04-28" @default.
• W1787542384 modified "2023-10-16" @default.
• W1787542384 title "Adjuvant chemotherapy for early breast cancer: Is cyclophosphamide, methotrexate and 5-fluorouracil still the standard?" @default.
• W1787542384 cites W1262485082 @default.
• W1787542384 cites W1524417847 @default.
• W1787542384 cites W1723350107 @default.
• W1787542384 cites W1842248410 @default.
• W1787542384 cites W1848579801 @default.
• W1787542384 cites W1863343593 @default.
• W1787542384 cites W1882532563 @default.
• W1787542384 cites W1896390601 @default.
• W1787542384 cites W1955291661 @default.
• W1787542384 cites W1968380749 @default.
• W1787542384 cites W1973286526 @default.
• W1787542384 cites W2033763076 @default.
• W1787542384 cites W2036067444 @default.
• W1787542384 cites W2066801806 @default.
• W1787542384 cites W2078053549 @default.
• W1787542384 cites W2091485767 @default.
• W1787542384 cites W2107950489 @default.
• W1787542384 cites W2114081348 @default.
• W1787542384 cites W2118575650 @default.
• W1787542384 cites W2132737479 @default.
• W1787542384 cites W2135800076 @default.
• W1787542384 cites W2138045238 @default.
• W1787542384 cites W2138440511 @default.
• W1787542384 cites W2138602439 @default.
• W1787542384 cites W2150382961 @default.
• W1787542384 cites W2214029008 @default.
• W1787542384 cites W2225669013 @default.
• W1787542384 cites W2226691778 @default.
• W1787542384 cites W2241129238 @default.
• W1787542384 cites W2253920138 @default.
• W1787542384 cites W2266844702 @default.
• W1787542384 cites W2335332412 @default.
• W1787542384 cites W2338983050 @default.
• W1787542384 cites W2313308602 @default.
• W1787542384 doi "https://doi.org/10.1111/j.1743-7563.2005.00004.x" @default.
• W1787542384 hasPublicationYear "2005" @default.
• W1787542384 type Work @default.
• W1787542384 sameAs 1787542384 @default.
• W1787542384 citedByCount "1" @default.
• W1787542384 countsByYear W17875423842013 @default.
• W1787542384 crossrefType "journal-article" @default.
• W1787542384 hasAuthorship W1787542384A5021904433 @default.
• W1787542384 hasAuthorship W1787542384A5045781394 @default.
• W1787542384 hasAuthorship W1787542384A5047266225 @default.
• W1787542384 hasBestOaLocation W17875423841 @default.
• W1787542384 hasConcept C121608353 @default.
• W1787542384 hasConcept C126322002 @default.
• W1787542384 hasConcept C143998085 @default.
• W1787542384 hasConcept C207103383 @default.
• W1787542384 hasConcept C2776694085 @default.
• W1787542384 hasConcept C2776755627 @default.
• W1787542384 hasConcept C2776802502 @default.
• W1787542384 hasConcept C2777511904 @default.
• W1787542384 hasConcept C2777863537 @default.
• W1787542384 hasConcept C2777909004 @default.
• W1787542384 hasConcept C2780456651 @default.
• W1787542384 hasConcept C2781059491 @default.
• W1787542384 hasConcept C44249647 @default.
• W1787542384 hasConcept C526805850 @default.
• W1787542384 hasConcept C530470458 @default.
• W1787542384 hasConcept C71924100 @default.
• W1787542384 hasConceptScore W1787542384C121608353 @default.
• W1787542384 hasConceptScore W1787542384C126322002 @default.
• W1787542384 hasConceptScore W1787542384C143998085 @default.
• W1787542384 hasConceptScore W1787542384C207103383 @default.
• W1787542384 hasConceptScore W1787542384C2776694085 @default.
• W1787542384 hasConceptScore W1787542384C2776755627 @default.
• W1787542384 hasConceptScore W1787542384C2776802502 @default.
• W1787542384 hasConceptScore W1787542384C2777511904 @default.
• W1787542384 hasConceptScore W1787542384C2777863537 @default.
• W1787542384 hasConceptScore W1787542384C2777909004 @default.
• W1787542384 hasConceptScore W1787542384C2780456651 @default.
• W1787542384 hasConceptScore W1787542384C2781059491 @default.
• W1787542384 hasConceptScore W1787542384C44249647 @default.
• W1787542384 hasConceptScore W1787542384C526805850 @default.
• W1787542384 hasConceptScore W1787542384C530470458 @default.
• W1787542384 hasConceptScore W1787542384C71924100 @default.
• W1787542384 hasIssue "1" @default.
• W1787542384 hasLocation W17875423841 @default.
• W1787542384 hasOpenAccess W1787542384 @default.
• W1787542384 hasPrimaryLocation W17875423841 @default.
• W1787542384 hasRelatedWork W1989798994 @default.
• W1787542384 hasRelatedWork W1994904178 @default.
• W1787542384 hasRelatedWork W2040681136 @default.
• W1787542384 hasRelatedWork W2056019683 @default.
• W1787542384 hasRelatedWork W2057035116 @default.
• W1787542384 hasRelatedWork W2078063140 @default.
• W1787542384 hasRelatedWork W2131637014 @default.
• W1787542384 hasRelatedWork W2400882587 @default.
• W1787542384 hasRelatedWork W2442348499 @default.

• next